Little Green Pharma Ltd (ASX:LGP)
0.1200
-0.0050 (-4.00%)
Dec 5, 2025, 4:10 PM AEST
Little Green Pharma Revenue
Little Green Pharma had revenue of 19.18M AUD in the half year ending September 30, 2025, with 34.31% growth. This brings the company's revenue in the last twelve months to 38.49M, up 26.76% year-over-year. In the fiscal year ending March 31, 2025, Little Green Pharma had annual revenue of 36.84M with 35.85% growth.
Revenue (ttm)
38.49M
Revenue Growth
+26.76%
P/S Ratio
0.95
Revenue / Employee
n/a
Employees
94
Market Cap
36.68M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 36.84M | 9.72M | 35.85% |
| Mar 31, 2024 | 27.12M | 7.26M | 36.55% |
| Mar 31, 2023 | 19.86M | 5.82M | 41.45% |
| Mar 31, 2022 | 14.04M | 7.04M | 100.47% |
| Jun 30, 2021 | 7.00M | 4.80M | 217.77% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Ramsay Health Care | 17.79B |
| Sonic Healthcare | 9.65B |
| Ansell | 3.06B |
| Cochlear | 2.34B |
| Regis Healthcare | 1.16B |
| Telix Pharmaceuticals | 1.01B |
| Neuren Pharmaceuticals | 218.86M |